The cardio-renal-anaemia syndrome predicts survival in peritoneally dialyzed patients

Introduction Anaemia is one of the arms of the cardio-renal-anaemia syndrome (CRA) in chronic kidney disease (CKD) patients. The correction of anaemia was effective in the amelioration of both cardiac and renal failure. We studied the relationship between the severity of CRA syndrome in peritoneally dialyzed patients and their survival probability. Material and methods Fifty-six patients on peritoneal dialysis were followed for 1 year. Definition of the severity of the CRA in dialysis patients: cardiac arm – NYHA class I-IV = 1-4 points, renal arm – non-diabetic patients age < 65 =1 point, non-diabetic patients age>65 = 2 points, diabetic patients age < 65 = 3 points, diabetic patients age>65 = 4 points, anaemia arm – Hb 11-13 g/dl (male), 11-12 g/dl (female) = 1 point, Hb 10-11 g/dl = 2 points, Hb 9-10 g/dl = 3 points, Hb < 9 g/dl = 4 points. The severity score = cardiac + renal + anaemia arms score divided by 3 (maximum 4 points). Results A total of 10/56 patients (18%) died during the study. The median value for the severity score of the whole group was 1.69. In Kaplan-Meier analysis CRA severity score was strongly associated with mortality (p < 0.001). It also correlated with albumin, CRP, erythropoietin treatment, Hb and fasting glucose. In the multivariate regression analysis age, Hb, albumin, and presence of diabetes remained significant predictors of death. Conclusions The severity score of CRA syndrome in peritoneally dialyzed patients is an independent and very significant predictor of death. The patients with a high severity score had more hypoalbuminaemia, higher inflammation markers and higher prevalence of diabetes and chronic heart failure. Cardio-renal-anaemia syndrome severity scoring as defined by us could be an easy tool to predict outcome of dialysis patients.

[1]  C. R. Emperador,et al.  The cardiorenal anemia syndrome , 2010 .

[2]  D. Schwartz,et al.  The Anemia of Heart Failure , 2009, Acta Haematologica.

[3]  R. Foley,et al.  Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  I. Anand Anemia and chronic heart failure implications and treatment options. , 2008, Journal of the American College of Cardiology.

[5]  E. Ducasse,et al.  Rio de La Plata study: a multicenter, cross-sectional study on cardiovascular risk factors and heart failure prevalence in peritoneal dialysis patients in Argentina and Uruguay. , 2008, Kidney international. Supplement.

[6]  D. Silverberg,et al.  Anaemia in heart failure: a common interaction with renal insufficiency called the cardio‐renal anaemia syndrome , 2007, International journal of clinical practice.

[7]  D. J. Veldhuisen,et al.  Levels of Hematopoiesis Inhibitor N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Partially Explain the Occurrence of Anemia in Heart Failure , 2005, Circulation.

[8]  A. Murray,et al.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.

[9]  S. Yusuf,et al.  Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. , 2005, Journal of the American College of Cardiology.

[10]  D. Silverberg,et al.  The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron? , 2004, Journal of nephrology.

[11]  C. O'connor,et al.  Anemia as a risk factor and therapeutic target in heart failure. , 2004, Journal of the American College of Cardiology.

[12]  D. Schwartz,et al.  Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure. , 2004, International journal of cardiology.

[13]  D. Schwartz,et al.  The Interaction between Heart Failure, Renal Failure and Anemia – The Cardio-Renal Anemia Syndrome , 2004, Blood Purification.

[14]  D. Silverberg,et al.  Erythropoietin should be part of congestive heart failure management. , 2003, Kidney international. Supplement.

[15]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.

[16]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[17]  G. Bakris,et al.  Heart failure as a cause for hospitalization in chronic dialysis patients. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  Paul W Armstrong,et al.  Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[19]  A. Levin,et al.  Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. , 2002, Kidney international. Supplement.

[20]  W. Bloembergen,et al.  A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  W. Rand,et al.  Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.

[22]  I. Shapira,et al.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.

[23]  David C. Murray,et al.  The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  David C. Murray,et al.  Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. , 1995, Kidney international.

[25]  N. Dimkovic,et al.  [The cardio-renal anemia syndrome]. , 2007, Medicinski pregled.

[26]  D. Schwartz,et al.  Anemia, chronic renal disease and congestive heart failure—the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists , 2006, International Urology and Nephrology.

[27]  Tsutomu Inoue,et al.  Risk factors for vascular complications in patients on peritoneal dialysis. , 2006, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[28]  M. Delgado,et al.  Survival on chronic dialysis: 10 years' experience of a single Colombian center. , 2005, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[29]  P. Doevendans,et al.  Renal function; , 2004 .

[30]  R. Foley,et al.  Anemia and Cardiovascular Disease, Hospitalization, End Stage Renal Disease, and Death in Older Patients with Chronic Kidney Disease , 2004, International Urology and Nephrology.